Li Zhao
- Molecular Biology top 2%
- Pharmacology top 0.5%
- Plant Science top 2%
- Oncology top 5%
- Cancer Research top 2%
- Topics
- Flavonoids in Medical Research (20 papers)Natural product bioactivities and synthesis (15 papers)Cancer, Hypoxia, and Metabolism (13 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li Zhao
193 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 145
- Molecular Biology 2.6k
- Pharmacology 1.2k
- Plant Science 1.0k
- Oncology 823
- Cancer Research 806
Countries citing papers authored by Li Zhao
This map shows the geographic impact of Li Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhao more than expected).
Fields of papers citing papers by Li Zhao
This network shows the impact of papers produced by Li Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhao. The network helps show where Li Zhao may publish in the future.
Co-authorship network of co-authors of Li Zhao
This figure shows the co-authorship network connecting the top 25 collaborators of Li Zhao. A scholar is included among the top collaborators of Li Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zhao. Li Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 5 | |
| 11 | 0 | |
| 12 | 11 | |
| 13 | 11 | |
| 14 | 0 | |
| 15 | 19 | |
| 16 | 7 | |
| 17 | 40 | |
| 18 | 61 | |
| 19 | A study on the treatment of chronic hepatitis B with YMDD mutation | 1 |
| 20 | Gambogic acid inducing apoptosis in human gastric adenocarcinoma SGC-7901 cells | 12 |
About Li Zhao
Li Zhao is a scholar working on Pharmacology, Cancer Research and Molecular Biology, having authored 207 papers that have together received 5.1k indexed citations. Recurring topics across this work include Flavonoids in Medical Research (20 papers), Natural product bioactivities and synthesis (15 papers) and Cancer, Hypoxia, and Metabolism (13 papers). The work is most often cited by research in Pharmacology (1.2k citations), Toxicology (201 citations) and Cancer Research (806 citations). Li Zhao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Qinglong Guo, Qidong You, Na Lu, Hong-Yan Gu, Yong Yang, Zhiyu Li, Jing Yao, Lei Qiang, Di Pan and Xiaotang Wang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.